[go: up one dir, main page]

SE9703287D0 - Peptides - Google Patents

Peptides

Info

Publication number
SE9703287D0
SE9703287D0 SE9703287A SE9703287A SE9703287D0 SE 9703287 D0 SE9703287 D0 SE 9703287D0 SE 9703287 A SE9703287 A SE 9703287A SE 9703287 A SE9703287 A SE 9703287A SE 9703287 D0 SE9703287 D0 SE 9703287D0
Authority
SE
Sweden
Prior art keywords
peptide
nucleic acid
peptides
mog
screening
Prior art date
Application number
SE9703287A
Other languages
Swedish (sv)
Inventor
Magnus Andersson
Christopher Linington
Tomas Olsson
Erik Wallstroem
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9703287A priority Critical patent/SE9703287D0/en
Publication of SE9703287D0 publication Critical patent/SE9703287D0/en
Priority to EP98944386A priority patent/EP1012183A1/en
Priority to AU91938/98A priority patent/AU9193898A/en
Priority to CA002301684A priority patent/CA2301684A1/en
Priority to PCT/SE1998/001618 priority patent/WO1999012966A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)

Abstract

There is provided according to the present invention, a peptide comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein (MOG), nucleic acid molecules capable of encoding the peptide and the use of such peptide or nucleic acid in medical therapy or screening.
SE9703287A 1997-09-11 1997-09-11 Peptides SE9703287D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9703287A SE9703287D0 (en) 1997-09-11 1997-09-11 Peptides
EP98944386A EP1012183A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
AU91938/98A AU9193898A (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
CA002301684A CA2301684A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
PCT/SE1998/001618 WO1999012966A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703287A SE9703287D0 (en) 1997-09-11 1997-09-11 Peptides

Publications (1)

Publication Number Publication Date
SE9703287D0 true SE9703287D0 (en) 1997-09-11

Family

ID=20408221

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703287A SE9703287D0 (en) 1997-09-11 1997-09-11 Peptides

Country Status (5)

Country Link
EP (1) EP1012183A1 (en)
AU (1) AU9193898A (en)
CA (1) CA2301684A1 (en)
SE (1) SE9703287D0 (en)
WO (1) WO1999012966A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
CA2328612A1 (en) * 1998-05-19 1999-11-25 Yeda Research And Development Co., Ltd. Activated t cells, nervous system-specific antigens and their uses
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ273813A (en) * 1993-09-03 1998-05-27 Immulogic Pharma Corp Myelin oligodendrocyte glycoprotein autoantigen
WO1995007096A1 (en) * 1993-09-06 1995-03-16 La Trobe University Treatment of autoimmune disease
SI9520118A (en) * 1994-10-25 1998-08-31 Immulogic Pharmaceutical Corporation Compositions and treatment for multiple sclerosis
WO1997035879A1 (en) * 1996-03-28 1997-10-02 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof

Also Published As

Publication number Publication date
CA2301684A1 (en) 1999-03-18
AU9193898A (en) 1999-03-29
WO1999012966A1 (en) 1999-03-18
EP1012183A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
ATE386538T1 (en) COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES
EP2258383A3 (en) Antigenic peptides derived from telomerase
RU95115239A (en) Erythropoietin analog
BR0213786A (en) Effective peptides in treating tumors and other conditions requiring cell removal or destruction
DE69738581D1 (en) HUMAN DNASE I HYPERACTIVE VARIANTS
CY1111120T1 (en) Peptides Derived from Protein Nerve Fibers and Their Medical Use
DE69630890D1 (en) PEPTID-IMITATING SUBSTANCES IN CANCER THERAPY
FR2705361B1 (en) Viral vectors and use in gene therapy.
HUP0204199A2 (en) Transport vectors
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
DE60213648D1 (en) USE OF THYMULENTAL PEPTIDES FOR THE PREPARATION OF PAIN
ES2168361T3 (en) DNA SEQUENCES FOR METALOPROTEASES OF THE MATRIX, ITS PREPARATION AND EMPLOYMENT.
AR002742A1 (en) ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA
DE69931482D1 (en) ISOLATED PEPTIDES CORRESPOND TO THE AMINO ACID SEQUENCES OF NY-ESO-1 AND BIND MOLECULES AT MHC CLASS I AND MHC CLASS II, AND THEIR USES
ATE443076T1 (en) PROTEASE TYPE II CLAVEABLE PEPTIDE
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
ES8704207A1 (en) Rhinovirus strain HRV2 polypeptides and DNA molecules encoding them.
SE9703287D0 (en) Peptides
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
EP1702985A3 (en) Preferred segments of neural thread protein and methods of using the same
DE59410423D1 (en) SERIN-THREONINE-KINASE CONTAINING TUMOR THERAPY AND TUMOR DIAGNOSIS
DE69738600D1 (en) NEUROACTIVE PEPTIDES
DE69726602D1 (en) Hepatitis b inhibitoren
NO973876D0 (en) Human DNase I variants